Trial Profile
A phase I, open-label, fixed-sequence, multiple-dose study to evaluate the pharmacokinetic/pharmacodynamic (PK/PD) between sofosbuvir or ledipasvir and ethinylestradiol/norgestimate in healthy female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary) ; Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Pharmacokinetics
- 10 Dec 2015 New trial record